Literature DB >> 12700434

Increased frequency of HLA A2/DR4 and A2/DR8 haplotypes in young saskatchewan aboriginal people with diabetic end-stage renal disease.

Roland Dyck1, Clara Bohm, Helena Klomp.   

Abstract

AIMS: To determine the association of HLA with diabetic end-stage renal disease (DESRD) in Saskatchewan aboriginal people.
METHODS: This was a retrospective study of HLA profiles in four groups of Saskatchewan residents with ESRD diagnosed from 1980 to 1998: aboriginal people with and without DESRD, and non-aboriginal people with and without DESRD. The aboriginal DESRD group was also subdivided into those <or=50 and >50 years of age. Frequencies of individual and combinations of HLA antigens were compared between groups and subgroups.
RESULTS: HLA data were available for 634 subjects. Young aboriginal people with DESRD had a higher frequency of HLA-A2 than older AB DESRD subjects (69 vs. 36%; p = 0.03), and of HLA-DR4 and/or DR8 compared to older AB DESRD subjects (91 vs. 68%; p = 0.07) and AB non-DESRD subjects (91 vs. 67%; p = 0.03). Over 65% of young AB DESRD subjects had either an A2/DR4 or A2/DR8 haplotype (odds ratio 5.09 [confidence intervals 1.35, 20.15] versus older AB DESRD subjects; odds ratio 3.32 [confidence intervals 1.20, 9.3] versus AB non-DESRD subjects). Forty percent of young AB DESRD subjects were homozygous for at least one of A2, DR4 or DR8.
CONCLUSIONS: Our findings suggest that DESRD in young AB subjects with T2DM has a genetic basis related to HLA. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700434     DOI: 10.1159/000070747

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  8 in total

Review 1.  Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.

Authors:  Santiago Avila-Rios; Jonathan M Carlson; Mina John; Simon Mallal; Zabrina L Brumme
Journal:  Curr Opin HIV AIDS       Date:  2019-05       Impact factor: 4.283

2.  Association of selective HLA class II susceptibility-conferring and protective haplotypes with type 2 diabetes in patients from Bahrain and Lebanon.

Authors:  Wassim Y Almawi; Saria F Wakim-Ghorayeb; Mona R Arekat; Pierre Najm; Sose H Keleshian; Nasreen Al-Sayed; Bruno Blanchon; Hanady R Samaha; Noha Irani-Hakime
Journal:  Clin Vaccine Immunol       Date:  2006-09-20

3.  Prevalence, determinants and co-morbidities of chronic kidney disease among First Nations adults with diabetes: results from the CIRCLE study.

Authors:  Roland F Dyck; Mariam Naqshbandi Hayward; Stewart B Harris
Journal:  BMC Nephrol       Date:  2012-07-09       Impact factor: 2.388

Review 4.  Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications.

Authors:  José M López-Novoa; Ana B Rodríguez-Peña; Alberto Ortiz; Carlos Martínez-Salgado; Francisco J López Hernández
Journal:  J Transl Med       Date:  2011-01-20       Impact factor: 5.531

5.  Association between human leucocyte antigen subtypes and risk of end stage renal disease in Taiwanese: a retrospective study.

Authors:  Ciou-Sia Dai; Chen-Chung Chu; Shin-Fan Chen; Chiao-Yin Sun; Marie Lin; Chin-Chan Lee
Journal:  BMC Nephrol       Date:  2015-10-30       Impact factor: 2.388

6.  Association between LTA, TNF and AGER polymorphisms and late diabetic complications.

Authors:  Eero Lindholm; Ekaterina Bakhtadze; Corrado Cilio; Elisabet Agardh; Leif Groop; Carl-David Agardh
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

7.  Extensive host immune adaptation in a concentrated North American HIV epidemic.

Authors:  Zabrina L Brumme; Natalie N Kinloch; Stephen Sanche; Alexander Wong; Eric Martin; Kyle D Cobarrubias; Paul Sandstrom; Paul N Levett; P Richard Harrigan; Jeffrey B Joy
Journal:  AIDS       Date:  2018-09-10       Impact factor: 4.177

8.  Perspectives of Saskatchewan researchers and community members on HIV-1 strains circulating in Saskatchewan.

Authors:  Linda Chelico; Alexandra King; Jann Ticknor; Michael McDonald; Ron Rosenes; Jason Mercredi; Jack Saddleback; Geri Bailey; Malcolm King
Journal:  AIDS       Date:  2020-11-01       Impact factor: 4.632

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.